{"name":"Guangzhou Double Bioproducts Co., Ltd","slug":"guangzhou-double-bioproducts-co-ltd","ticker":"","exchange":"","domain":"","description":"Guangzhou Double Bioproducts Co., Ltd is a biotechnology company focused on the research, development, and commercialization of innovative oncology treatments. The company has a pipeline of three key drugs, including Endostatins and Cisplatin injection in Phase 3 trials, and Paclitaxel injection which is currently marketed.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Cisplatin injection","genericName":"Cisplatin injection","slug":"cisplatin-injection","indication":"Metastatic testicular cancer","status":"phase_3"},{"name":"Paclitaxel injection","genericName":"Paclitaxel injection","slug":"paclitaxel-injection","indication":"Metastatic carcinoma of the ovary","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Endostatins","genericName":"Endostatins","slug":"endostatins","indication":"Other","status":"phase_3"}]}],"pipeline":[{"name":"Cisplatin injection","genericName":"Cisplatin injection","slug":"cisplatin-injection","phase":"phase_3","mechanism":"Cisplatin is a platinum-based chemotherapy agent that forms DNA crosslinks, preventing DNA replication and transcription in cancer cells.","indications":["Metastatic testicular cancer","Metastatic ovarian cancer","Advanced bladder cancer","Head and neck cancer","Non-small cell lung cancer"],"catalyst":""},{"name":"Endostatins","genericName":"Endostatins","slug":"endostatins","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Paclitaxel injection","genericName":"Paclitaxel injection","slug":"paclitaxel-injection","phase":"marketed","mechanism":"Paclitaxel stabilizes microtubules by binding to β-tubulin, preventing their depolymerization and causing cell cycle arrest and apoptosis in cancer cells.","indications":["Metastatic carcinoma of the ovary","Breast cancer (metastatic and adjuvant)","Non-small cell lung cancer","Kaposi sarcoma","Head and neck cancer"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":3,"phaseCounts":{"phase_3":2,"marketed":1},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}